Myalgias causing an inability to ambulate after a viral illness is a concerning presentation for children, their parents and healthcare providers. Benign acute childhood myositis (BACM) and post-viral myositis (PVM) are typically distinguishable from juvenile dermatomyositis (JDM), but in exceedingly rare cases, they may present similarly, complicating the diagnosis. We report a unique case of a 4-year-old boy with severe myalgias and inability to ambulate following a norovirus infection. He also exhibited periorbital edema resembling a heliotrope rash, accompanied by significantly elevated levels of creatine kinase (CK), alanine transaminase (ALT), and aspartate transaminase (AST), raising concern for juvenile dermatomyositis, especially as he had a poor response to conservative medical management and his symptoms had persisted for two months. This case underscores the diagnostic challenges in distinguishing BACM/PVM from JDM, particularly when an uncommon viral pathogen like norovirus presents with a heliotrope rash—an eruption often considered pathognomonic for dermatomyositis.
References
[1]
Mammen, A.L., Casciola-Rosen, L., Christopher-Stine, L., Lloyd, T.E. and Wagner, K.R. (2015) Myositis-Specific Autoantibodies Are Specific for Myositis Compared to Genetic Muscle Disease. Neurology Neuroimmunology & Neuroinflammation, 2, e172. https://doi.org/10.1212/nxi.0000000000000172
[2]
Montagnese, F., Babačić, H., Eichhorn, P. and Schoser, B. (2019) Evaluating the Diagnostic Utility of New Line Immunoassays for Myositis Antibodies in Clinical Practice: A Retrospective Study. Journal of Neurology, 266, 1358-1366. https://doi.org/10.1007/s00415-019-09266-4
[3]
Magee, H. and Goldman, R.D. (2017) Viral Myositis in Children. Canadian Family Physician, 63, 365-368.
Brisca, G., Mariani, M., Pirlo, D., Romanengo, M., Pistorio, A., Gaiero, A., et al. (2021) Management and Outcome of Benign Acute Childhood Myositis in Pediatric Emergency Department. Italian Journal of Pediatrics, 47, Article No. 57. https://doi.org/10.1186/s13052-021-01002-x
[6]
Mall, S., Buchholz, U., Tibussek, D., Jurke, A., An der Heiden, M., Diedrich, S., et al. (2011) A Large Outbreak of Influenza B-Associated Benign Acute Childhood Myositis in Germany, 2007/2008. Pediatric Infectious Disease Journal, 30, e142-e146. https://doi.org/10.1097/inf.0b013e318217e356
[7]
Pippin, M., Stansbury, W. and Budde, P. (2024) Viral Myositis in an Eight-Year-Old. Cureus, 16, e56887. https://doi.org/10.7759/cureus.56887
[8]
Singh, H., Talapatra, P., Arya, S. and Gupta, V. (2013) Viral Myositis as a Close Mimicker of Polymyositis. Annals of Tropical Medicine and Public Health, 6, 324-326.
[9]
Agyeman, P., Duppenthaler, A., Heininger, U. and Aebi, C. (2004) Influenza-Associated Myositis in Children. Infection, 32, 199-203. https://doi.org/10.1007/s15010-004-4003-2
Narayanappa, G. and Nandeesh, B.N. (2021) Infective Myositis. Brain Pathology, 31, e12950. https://doi.org/10.1111/bpa.12950
[12]
Yamamoto, K., Fukuda, S., Mushimoto, Y., Minami, N., Kanai, R., Tsukamoto, K., et al. (2015) Acute Myositis Associated with Concurrent Infection of Rotavirus and Norovirus in a 2-Year-Old Girl. Pediatric Reports, 7, Article 5873. https://doi.org/10.4081/pr.2015.5873
[13]
Nishio, T., Yonetani, R., Ito, E., Yoneta, M., Maruo, Y., Yoshida, T., et al. (2016) Development of Rhabdomyolysis in a Child after Norovirus Gastroenteritis. BMC Pediatrics, 16, Article No. 176. https://doi.org/10.1186/s12887-016-0720-9
[14]
Walling, H.W., Gerami, P. and Sontheimer, R.D. (2010) Juvenile-Onset Clinically Amyopathic Dermatomyositis. Pediatric Drugs, 12, 23-34. https://doi.org/10.2165/10899380-000000000-00000
[15]
Papadopoulou, C., Chew, C., Wilkinson, M.G.L., McCann, L. and Wedderburn, L.R. (2023) Juvenile Idiopathic Inflammatory Myositis: An Update on Pathophysiology and Clinical Care. Nature Reviews Rheumatology, 19, 343-362. https://doi.org/10.1038/s41584-023-00967-9
[16]
Wedderburn, L.R. and Rider, L.G. (2009) Juvenile Dermatomyositis: New Developments in Pathogenesis, Assessment and Treatment. Best Practice & Research Clinical Rheumatology, 23, 665-678. https://doi.org/10.1016/j.berh.2009.07.007
[17]
Pachman, L.M., Nolan, B.E., DeRanieri, D. and Khojah, A.M. (2021) Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy. Current Treatment Options in Rheumatology, 7, 39-62. https://doi.org/10.1007/s40674-020-00168-5
[18]
Deakin, C.T., Bowes, J., Rider, L.G., Miller, F.W., Pachman, L.M., Sanner, H., et al. (2022) Association with HLA-DRβ1 Position 37 Distinguishes Juvenile Dermatomyositis from Adult-Onset Myositis. Human Molecular Genetics, 31, 2471-2481. https://doi.org/10.1093/hmg/ddac019
[19]
Pinal-Fernandez, I. and Mammen, A.L. (2018) Dermatomyositis Etiopathogenesis: A Rebel Soldier in the Muscle. Current Opinion in Rheumatology, 30, 623-629. https://doi.org/10.1097/bor.0000000000000540
[20]
Gambino, C.M., Aiello, A., Accardi, G., Caruso, C. and Candore, G. (2018) Autoimmune Diseases and 8.1 Ancestral Haplotype: An Update. HLA, 92, 137-143. https://doi.org/10.1111/tan.13305
[21]
Mamyrova, G., Rider, L.G., Ehrlich, A., Jones, O., Pachman, L.M., Nickeson, R., et al. (2017) Environmental Factors Associated with Disease Flare in Juvenile and Adult Dermatomyositis. Rheumatology, 56, 1342-1347. https://doi.org/10.1093/rheumatology/kex162
[22]
Bax, C.E., Maddukuri, S., Ravishankar, A., Pappas-Taffer, L. and Werth, V.P. (2021) Environmental Triggers of Dermatomyositis: A Narrative Review. Annals of Translational Medicine, 9, 434-434. https://doi.org/10.21037/atm-20-3719
[23]
Sassetti, C., Borrelli, C., Mazuy, M., Turrini, I., Rigante, D. and Esposito, S. (2024) The Relationship between Infectious Agents and Juvenile Dermatomyositis: A Narrative Update from the Pediatric Perspective. Frontiers in Immunology, 15, Article 1377952. https://doi.org/10.3389/fimmu.2024.1377952
[24]
Qian, J. and Xu, H. (2022) COVID-19 Disease and Dermatomyositis: A Mini-Review. Frontiers in Immunology, 12, Article 747116. https://doi.org/10.3389/fimmu.2021.747116
[25]
Orione, M.A.M., Silva, C.A., Sallum, A.M.E., Campos, L.M.A., Omori, C.H., Braga, A.L.F., et al. (2014) Risk Factors for Juvenile Dermatomyositis: Exposure to Tobacco and Air Pollutants during Pregnancy. Arthritis Care & Research, 66, 1571-1575. https://doi.org/10.1002/acr.22358
[26]
Mehta, P., Machado, P.M. and Gupta, L. (2021) Understanding and Managing Anti-MDA 5 Dermatomyositis, Including Potential COVID-19 Mimicry. Rheumatology International, 41, 1021-1036. https://doi.org/10.1007/s00296-021-04819-1
[27]
Greco, T.P., Askenase, P.W. and Kashgarian, M. (1977) Postviral Myositis: Myxovirus-Like Structures in Affected Muscle. Annals of Internal Medicine, 86, 193-194. https://doi.org/10.7326/0003-4819-86-2-193
[28]
Kessler, H.A. (1980) Acute Myopathy Associated with Influenza A/Texas/1/77 Infection. Isolation of Virus from a Muscle Biopsy Specimen. JAMA, 243, 461-462. https://doi.org/10.1001/jama.1980.03300310049022
[29]
Davis, L.E. and Kornfeld, M. (2001) Experimental Influenza B Viral Myositis. Journal of the Neurological Sciences, 187, 61-67. https://doi.org/10.1016/s0022-510x(01)00526-3
[30]
Gamboa, E.T., Eastwood, A.B., Hays, A.P., Maxwell, J. and Penn, A.S. (1979) Isolation of Influenza Virus from Muscle in Myoglobinuric Polymyositis. Neurology, 29, 1323-1335. https://doi.org/10.1212/wnl.29.10.1323
[31]
Servidei, S., Miranda, A.F. and Gamboa, E.T. (1987) Infectivity of Influenza B Virus in Cultured Human Muscle. Acta Neuropathologica, 73, 67-76. https://doi.org/10.1007/bf00695504
[32]
Bolko, L., Jiang, W., Tawara, N., Landon‐Cardinal, O., Anquetil, C., Benveniste, O., et al. (2021) The Role of Interferons Type I, II and III in Myositis: A Review. Brain Pathology, 31, e12955. https://doi.org/10.1111/bpa.12955
[33]
Arshanapalli, A., Shah, M., Veerula, V. and Somani, A. (2015) The Role of Type I Interferons and Other Cytokines in Dermatomyositis. Cytokine, 73, 319-325. https://doi.org/10.1016/j.cyto.2014.11.026
[34]
El-Zayat, S.R., Sibaii, H. and Mannaa, F.A. (2019) Toll-Like Receptors Activation, Signaling, and Targeting: An Overview. Bulletin of the National Research Centre, 43, Article No. 187. https://doi.org/10.1186/s42269-019-0227-2
[35]
Bove, K.E., Hilton, P.K., Partin, J. and Farrell, M.K. (1983) Morphology of Acute Myopathy Associated with Influenza B Infection. Pediatric Pathology, 1, 51-66. https://doi.org/10.3109/15513818309048284
[36]
Cassard, L., Seraly, N., Riegert, M., Patel, A. and Fernandez, A. (2024) Dermatomyositis: Practical Guidance and Unmet Needs. ImmunoTargets and Therapy, 13, 151-172. https://doi.org/10.2147/itt.s381472
[37]
Wolstencroft, P.W., Rieger, K.E., Leatham, H.W. and Fiorentino, D.F. (2019) Clinical Factors Associated with Cutaneous Histopathologic Findings in Dermatomyositis. Journal of Cutaneous Pathology, 46, 401-410. https://doi.org/10.1111/cup.13442
[38]
Alsaad, K.O. and Ghazarian, D. (2005) My Approach to Superficial Inflammatory Dermatoses. Journal of Clinical Pathology, 58, 1233-1241. https://doi.org/10.1136/jcp.2005.027151
[39]
Horn, T.D. and Junkins-Hopkins, J.M. (2020) Chapter 3: Interface Dermatitis. In: Barnhill, R.L., Crowson, A., Magro, C.M., Piepkorn, M.W., Kutzner, H. and Desman, G.T., Eds., Barnhill’s Dermatopathology, 4th Edition, McGraw Hill Education. https://dermatology.mhmedical.com/content.aspx?bookid=2802§ionid=238126718
[40]
Zandee van Rilland, E.D., Yao, L., Stevens, K.J., Chung, L.S., Fiorentino, D.F. and Boutin, R.D. (2024) Myositis and Its Mimics: Guideline Updates, MRI Characteristics, and New Horizons. American Journal of Roentgenology, 223, e2431359. https://doi.org/10.2214/ajr.24.31359
[41]
Lundberg, I.E., Tjärnlund, A., Bottai, M., Werth, V.P., Pilkington, C., de Visser, M., et al. (2017) 2017 European League against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis & Rheumatology, 69, 2271-2282. https://doi.org/10.1002/art.40320
[42]
Sontheimer, R.D. (2002) Dermatomyositis: An Overview of Recent Progress with Emphasis on Dermatologic Aspects. Dermatologic Clinics, 20, 387-408. https://doi.org/10.1016/s0733-8635(02)00021-9
[43]
Concha, J.S.S., Tarazi, M., Kushner, C.J., Gaffney, R.G. and Werth, V.P. (2019) The Diagnosis and Classification of Amyopathic Dermatomyositis: A Historical Review and Assessment of Existing Criteria. British Journal of Dermatology, 180, 1001-1008. https://doi.org/10.1111/bjd.17536
[44]
Muro, Y., Sugiura, K. and Akiyama, M. (2016) Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features—A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 51, 293-302. https://doi.org/10.1007/s12016-015-8496-5
[45]
Swafford, C. and Roach, E.S. (2020) Juvenile Dermatomyositis and the Inflammatory Myopathies. Seminars in Neurology, 40, 342-348. https://doi.org/10.1055/s-0040-1705120
[46]
Da Silva, D.M., Patel, B. and Werth, V.P. (2018) Dermatomyositis: A Diagnostic Dilemma. Journal of the American Academy of Dermatology, 79, 371-373. https://doi.org/10.1016/j.jaad.2017.12.074
